Has Ian Sarembock received payments from drug or device companies?

Yes. Drug and device makers reported $98,090 in general payments to Ian Sarembock across 124 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ian Sarembock did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ian Sarembock come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ian Sarembock

Interventional Cardiology · Cincinnati, OHNPI 1922198613

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $88,233 of the $98,090 with a category attached, or 90.0%. 9 manufacturers reported payments, led by Boston Scientific at 48.9% of the total. Reporting peaked in 2020 at $28,021 and has fallen 62.3% since, to $10,575 in 2025. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$98,090in general payments, 2019–2025

Across 124 payments — averaging $791.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$48K
Medtronic$44K
Abbott$3K
W. L. Gore & Associates, Inc.$2K
Edwards Lifesciences$1K
Johnson & Johnson$27
plus $41 from 3 others

$167,868in research payments, 2019–2025

Across 50 payments — averaging $3357.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$95K
Edwards Lifesciences$72K
Boston Scientific$1K

What the payments were for

Consulting fees$88,23390%
Grants$4951%
Travel & lodging$5,9206%
Food & beverage$3,4414%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	39	$48,015
Medtronic(2 entities)	51	$44,092
Abbott	21	$2,857
W. L. Gore & Associates, Inc.	2	$1,750
Edwards Lifesciences	6	$1,308
Johnson & Johnson	2	$27
Amgen	1	$16
Portola Pharmaceuticals, LLC	1	$15
Bardy Diagnostics, Inc.	1	$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$98,090 in reported general payments places this provider in the 90th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio →

Other interventional cardiology in Cincinnati

Timothy HenryCincinnati$605K
John CorlCincinnati$390K
Santiago GarciaCincinnati$360K
Joseph ChooCincinnati$224K
Dean KereiakesCincinnati$139K
Puvi SeshiahCincinnati$81K
Raviteja GuddetiCincinnati$68K
Satya ShreenivasCincinnati$47K
Amer SayedCincinnati$31K
Zaid AlirhayimCincinnati$28K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →